CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,154 | -5.4% | 51,190 | 0.0% | 0.00% | – |
| Q2 2023 | $75,249 | -10.9% | 51,190 | 0.0% | 0.00% | – |
| Q1 2023 | $84,464 | +17.9% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $71,666 | -9.3% | 51,190 | 0.0% | 0.00% | – |
| Q3 2022 | $79,000 | -30.1% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $113,000 | -11.0% | 51,190 | 0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -58.8% | 51,190 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $308,000 | -11.7% | 51,190 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $349,000 | +2.6% | 52,349 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $340,000 | -35.8% | 51,190 | -10.5% | 0.00% | -50.0% |
| Q1 2021 | $530,000 | -76.4% | 57,220 | -54.1% | 0.00% | -75.0% |
| Q4 2020 | $2,245,000 | – | 124,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |